Wareham Insights

March is bringing strong momentum across our Bay Area Life Science and R&D campuses, with funding milestones, tenant growth, and industry conversations shaping the year ahead. From companies advancing new research to broader life science trends across the region, the…

Wareham Development recently welcomed the Berkeley Lab K-12 STEM team and East Bay high school students to the EmeryStation Research Campus for a STEM Career Day focused on exploring careers in science and research. Students had the opportunity to visit…

Building the Spaces That Power Tomorrow’s Breakthroughs For nearly 50 years, Wareham Development has focused on one mission: creating environments where breakthrough ideas can take shape and thrive. In a recent interview with the San Francisco Business Times, Founder and…

Wareham Development has signed a full-floor lease with CytomX Therapeutics at 5959 Horton Street, part of the EmeryStation Research Campus in Emeryville.  The oncology-focused pharmaceutical company plans to relocate from the Peninsula and begin moving into the 35,584-square-foot space in…

A new outlook from CBRE highlights several trends shaping the life sciences real estate market heading into 2026. The construction pipeline for lab and R&D space has slowed significantly, with approximately 6 million square feet currently underway nationwide. That is…

Why Adaptive Reuse Is Shaping the Future of Life Sciences Labs In today’s life sciences market, the question isn’t just where to build labs—it’s whether you should build or reuse. As funding cycles tighten, more companies are turning to reuse…